Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors



Status:Archived
Conditions:Skin Cancer, Cancer, Cancer, Brain Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:March 2009

Use our guide to learn which trials are right for you!

A Phase I, Multicenter, Open-label, Dose-escalation Study of Oral LDE225 in Patients With Advanced Solid Tumors


This first-in-human dose-escalation study is to characterize the safety, tolerability,
pharmacokinetics and pharmacodynamics of LDE225 given orally on a daily dosing schedule in
patients with advanced solid tumors.



We found this trial at
2
sites
San Antonio, Texas 78229
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
Pittsburgh, Pennsylvania 15260
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials